Tumor necrosis factor alpha in lung diseases
Zabel, P.; Schlaak, M.
Pneumologie 47(2): 49-52
1993
ISSN/ISBN: 0934-8387 PMID: 8464851 Document Number: 406263
Document emailed within 1 workday
Related Documents
Kaneko, H.; Yamada, H.; Mizuno, S.; Udagawa, T.; Kazumi, Y.; Sekikawa, K.; Sugawara, I. 1999: Role of tumor necrosis factor-alpha in Mycobacterium-induced granuloma formation in tumor necrosis factor-alpha-deficient mice Laboratory Investigation; a Journal of Technical Methods and Pathology 79(4): 379-386Broudy, V.C.; Harlan, J.M.; Adamson, J.W. 1987: Disparate effects of tumor necrosis factor-alpha/cachectin and tumor necrosis factor-beta/lymphotoxin on hematopoietic growth factor production and neutrophil adhesion molecule expression by cultured human endothelial cells Journal of Immunology 138(12): 4298-4302
Alsalameh, S.; Mattka, B.; Al-Ward, R.; Lorenz, H.M.; Manger, B.; Pfizenmaier, K.; Grell, M.; Kalden, J.R. 1999: Preferential expression of tumor necrosis factor receptor 55 (TNF-R55) on human articular chondrocytes: selective transcriptional upregulation of TNF-R75 by proinflammatory cytokines interleukin 1beta, tumor necrosis factor-alpha, and basis fibroblast growth factor Journal of Rheumatology 26(3): 645-653
Yang, L.-l.; Ji, X.-p.; Liu, Z. 2004: Effects of hypercapnia on nuclear factor-kappaB and tumor necrosis factor-alpha in acute lung injury models Chinese Medical Journal 117(12): 1859-1861
Bebök, Z.; Szekeres, G.; Horváth, G.; Duda, E.; Németh, P. 1993: Creation of monoclonal antibodies against tumor necrosis factor-alpha (TNF-alpha) and transforming growth factor alpha (TFG-alpha), their definition and possible use Orvosi Hetilap 134(24): 1303-1307
Dubaybo, B.A. 1998: Role of tumor necrosis factor-alpha in regulating fibrotic lung repair Research Communications in Molecular Pathology and Pharmacology 101(1): 69-83
Kopiński, P.; Dyczek, A.; Chorostowska-Wynimko, J.; Marszałek, A.; Balicka-Slusarczyk, B.; Kubiszewska, I.; Szabłowska, K.; Półgesek, E.; Szpechciński, A. 2012: Higher incidence of alveolar lymphocytes (AL) apoptosis in smokers depends on BCL-2 expression and specific response to tumor necrosis factor alpha (TNFalpha). Bronchoalveolar lavage (BAL) material analysis from selected interstitial lung diseases (ILD) and healthy controls Przeglad Lekarski 69(10): 731-736
Egido, J.; Gómez-Chiarri, M.; Ortíz, A.; Bustos, C.; Alonso, J.; Gómez-Guerrero, C.; Gómez-Garre, D.; López-Armada, M.J.; Plaza, J.; Gonzalez, E. 1993: Role of tumor necrosis factor-alpha in the pathogenesis of glomerular diseases Kidney International. Suppl 39: S59-S64
Girolomoni, G.; Pastore, S.; Albanesi, C.; Cavani, A. 2002: Targeting tumor necrosis factor-alpha as a potential therapy in inflammatory skin diseases Current Opinion in Investigational Drugs 3(11): 1590-1595
Fukumoto, T.; Uyama, T.; Sakiyama, S.; Tamaki, M.; Monden, Y. 1999: Persistently expressed interleukin-1 beta and tumor necrosis factor-alpha gene in accepted rat lung allografts Transplantation Proceedings 31(3): 1735-1739
Yang, S.C.; Owen-Schaub, L.; Mendiguren-Rodriguez, A.; Grimm, E.A.; Hong, W.K.; Roth, J.A. 1990: Combination immunotherapy for non-small cell lung cancer. Results with interleukin-2 and tumor necrosis factor-alpha Journal of Thoracic and Cardiovascular Surgery 99(1): 8
Zhao, Y.-x.; Wang, L.; Liu, D.; Yu, R.-j. 2006: Retinoic acid inhibits tumor necrosis factor-alpha induced injury in human lung epithelial cells Zhonghua Yi Xue Za Zhi 86(47): 3358-3361
Daniel, L.W.; Civoli, F.; Rogers, M.A.; Smitherman, P.K.; Raju, P.A.; Roederer, M. 1995: ET-18-OCH3 inhibits nuclear factor-kappa B activation by 12-O-tetradecanoylphorbol-13-acetate but not by tumor necrosis factor-alpha or interleukin 1 alpha Cancer Research 55(21): 4844-4849
Tanaka, N.; Kojima, K.; Muro, M.; Naomoto, Y.; Moreira, L.F.; Orita, K. 1995: Anti-proliferative and cytokinetic effects of tumor necrosis factor-alpha, interferon-alpha and 5-fluorouracil on a human tumor xenograft Anticancer Research 15(5b): 1949-1952
Solomatin, V.P.; Bredikhina, N.A. 2007: The role of tumor necrosis factors (TNF-alpha) in patients with chronic obstructive lung disease in combination with stomach and duodenum ulcer diseases Eksperimental'naia i Klinicheskaia Gastroenterologiia 4: 25-28
Villani, F.; Dell'Oca, I.; De Maria, P.; Viola, G.; Di Russo, A.; Viviani, S.; Bonfante, V. 1999: Lung function and serum concentration of tumor necrosis factor-alpha, interleukin-6 and fibronectin in patients treated with ABVD chemotherapy followed by radiotherapy for mediastinal Hodgkin's disease Anticancer Research 19(5c): 4475-4479
Ylitalo, K.; Peuhkurinen, K. 2001: Tumor necrosis factor alpha and the heart--can heart diseases be treated by neutralizing cytokines? Duodecim; Laaketieteellinen Aikakauskirja 117(3): 256-259
Zaremba, J.; Losy, J. 2001: Tumor necrosis factor alpha (TNF-alpha) in patients with ischemic stroke Neurologia i Neurochirurgia Polska 35(1): 41-46
Wang, Q.; Wu, X.; Wang, J.; Liu, H.; Li, L.; Jin, X. 2005: Building immune microsphere against tumor necrosis factor-alpha (TNF-alpha) Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 22(6): 1219-1222
Belaiche, J.; Louis, E. 2000: Treatment of Crohn disease in adults with tumor necrosis factor-alpha (TNF-alpha) antibodies Revue Medicale de Liege 55(9): 827-832